DA-057 - “The Luminous Vein Disease”
Object Class: Medium
Secure Containment Guidelines:
DA-057 is to be contained within a secure and isolated biohazard containment facility at Site-██. Access to DA-057 requires Level 4 clearance and must be authorized by at least two senior researchers. The containment chamber should be equipped with full spectrum surveillance cameras, biohazard suits, and isolation protocols to prevent the spread of DA-057.
Under no circumstances should DA-057 be allowed to spread outside the containment chamber. In the event of an outbreak or breach, the affected area must be quarantined immediately, and emergency response teams are to be deployed for containment and retrieval operations.
Description:
DA-057 is a highly contagious and virulent disease that affects the circulatory system of human beings. It is characterized by the luminescence of the veins, making them visible from outside the body. Affected individuals experience extreme pain and a significant drain in energy as the disease progresses.
The initial stages of infection involve the appearance of faint glowing patterns under the skin, primarily concentrated along the major blood vessels. As the disease progresses, the luminescent patterns become more pronounced and intense, causing the veins to emit a bright, visible glow. The affected veins appear to pulsate rhythmically, in synchrony with the heartbeat of the individual.
DA-057 is transmitted through direct contact with bodily fluids of infected individuals, including blood, saliva, and sweat. Airborne transmission has not been observed thus far. The disease has a high infection rate, with a rapid onset of symptoms in infected subjects, typically within 24 hours of exposure.
The pain experienced by infected individuals has been described as excruciating and unrelenting, with analgesics having little effect. As the disease progresses, victims report severe fatigue, loss of motor control, and eventual immobilization due to the overwhelming pain.
Addendum: Incident DA-057-1
On [DATE REDACTED], a containment breach occurred within Site-██, resulting in the release of a massive strand of DA-057. Several personnel members were exposed to the disease, and immediate quarantine protocols were initiated. Due to the highly contagious nature of DA-057, additional personnel and resources were deployed to contain the outbreak.
The infected personnel exhibited accelerated progression of the disease, with veins glowing intensely and experiencing severe pain. Despite efforts to administer pain relief and medical treatment, multiple casualties occurred, with individuals succumbing to the disease within hours of exposure.
Emergency response teams equipped with biohazard suits successfully isolated the infected area, preventing the further spread of DA-057. The affected personnel were contained, and subsequent decontamination procedures were implemented to mitigate any potential risks. Site-██ remained under quarantine for [DURATION REDACTED] until all traces of DA-057 were successfully neutralized.
Further research is ongoing to understand the origin, nature, and potential containment strategies for DA-057. Efforts are focused on developing effective treatments, prophylactics, and neutralization methods to mitigate the risks associated with the disease.
Incident DA-057-1 Recovery Logs:
[DATE REDACTED]
██: This is Agent █████, we have successfully contained the infected area. Casualties are in the double digits. We have established a perimeter, and biohazard teams are ready for decontamination.
Dr. ██████: Copy that, Agent █████. Ensure that all contaminated individuals are isolated and provided with necessary medical support. We need to gather as much information as possible for further analysis.
[DATE REDACTED]
Dr. ██████: Agent █████, what is the current status of the infected individuals?
Agent █████: Sir, it's grim. Despite our best efforts, most of them are in critical condition. We've lost communication with a few of the isolated subjects. The pain seems to be overwhelming.
Dr. ██████: Understood, Agent. Focus on containment and retrieval. We need to ensure the safety of the unaffected personnel. We'll continue researching possible treatment options.
[DATE REDACTED]
Dr. ██████: Agent █████, the containment procedures have been successful, and we are ready to begin the decontamination process. I want the affected area scrubbed clean. No traces of DA-057 should remain.
Agent █████: Roger that, Doctor. Biohazard teams are moving in for cleanup operations.
Closing Statement: The incident involving the outbreak of DA-057 within Site-██ has highlighted the need for enhanced containment measures and further research. Efforts are ongoing to prevent future breaches and develop effective countermeasures against DA-057. The potential risks associated with this Medium-class anomaly necessitate continued vigilance and caution in handling and containment procedures.